Sageworth Trust’s Bristol-Myers Squibb BMY Stock Holding History

Sageworth Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,794	Closed	-$442K	–	158
2025 Q3	$442K	Buy	+9,794	New	+$457K	0.02%	165
2023 Q2	–	Sell	-1,300	Closed	-$90.1K	–	128
2023 Q1	$90.1K	Sell	1,300 -16	-1%	-$1.13K	0.01%	110
2022 Q4	$95K	Buy	1,316 +16	+1%	+$1.21K	0.01%	102
2022 Q3	$92K	Hold	1,300	–	–	0.01%	94
2022 Q2	$100K	Hold	1,300	–	–	0.01%	139
2022 Q1	$95K	Buy	+1,300	New	+$87.3K	0.01%	80
2021 Q3	–	Sell	-175	Closed	-$12K	–	852
2021 Q2	$12K	Hold	175	–	–	﹤0.01%	538
2021 Q1	$11K	Hold	175	–	–	﹤0.01%	244
2020 Q4	$11K	Hold	175	–	–	﹤0.01%	175
2020 Q3	$11K	Sell	175 -23	-12%	-$1.38K	﹤0.01%	139
2020 Q2	$12K	Buy	198 +23	+13%	+$1.38K	﹤0.01%	126
2020 Q1	$10K	Hold	175	–	–	﹤0.01%	124
2019 Q4	$11K	Buy	+175	New	+$10K	﹤0.01%	150
2019 Q2	–	Sell	-200	Closed	-$10K	–	186
2019 Q1	$10K	Sell	200 -400	-67%	-$19.9K	﹤0.01%	168
2018 Q4	$31K	Hold	600	–	–	﹤0.01%	93
2018 Q3	$37K	Buy	600 +400	+200%	+$23.7K	0.01%	106
2018 Q2	$11K	Buy	+200	New	+$10.8K	﹤0.01%	105
2015 Q1	–	Sell	-5,169	Closed	-$305K	–	43
2014 Q4	$305K	Buy	+5,169	New	+$292K	0.09%	74

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Sageworth Trust's BMY Position: Q4 2025 in Review

Sageworth Trust sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 9,794 shares — an estimated $442K sold.

Sageworth Trust first reported a position in BMY in Q4 2014 and held it in 18 quarters. The position peaked at $442K in Q3 2025. 2,448 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

Sageworth Trust reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
Sageworth Trust sold 9,794 Bristol-Myers Squibb shares in Q4 2025, an estimated $442K.
Sageworth Trust first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 18 quarters.
Sageworth Trust's Bristol-Myers Squibb position peaked at $442K in Q3 2025.
2,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Sageworth Trust's 13F filing for Q4 2025, filed 3 Feb 2026.